ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1813

DNA Sensors Regulate Inflammation in a Model of Autoimmune Arthritis

Rebecca Baum1, Shruti Sharma2, Sudesh Pawaria3, Susan Carpenter4, Katherine A. Fitzgerald5, Ann Marshak-Rothstein6 and Ellen M. Gravallese7, 1Cell Biology, University of Massachusetts Medical School, Worcester, MA, 2Department of Medicine - Infectious Diseases Division, University of Massachusetts Medical School, Worcester, MA, 3Department of Medicine, University of Massachusetts Medical School, Worcester, MA, 4University of California, San Francisco, San Francisco, CA, 5Department of Medicine, Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, 6Department of Medicine, Division of Rheumatology, University of Massachusetts Medical School, Worcester, MA, 7Department of Medicine, Division of Rheumatology, UMass Memorial Medical Center, Worcester, MA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: ANA, arthritis and autoimmune diseases, DNA, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Innate Immunity and Rheumatic Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Innate immune sensors such as cytosolic DNA sensors and toll-like receptors (TLRs) detect viral or bacterial DNA, resulting in production of proinflammatory cytokines and type I IFNs to clear infection. Pathways involved in detecting this foreign DNA include: 1) cytosolic DNA sensors that signal through stimulator of interferon genes (STING); 2) the cytosolic sensor absent in melanoma 2 (AIM2); and 3) endosomal TLRs that traffic via Unc93. DNA derived from endogenous retroelements or dying cells have also been shown to activate these pathways, contributing to autoimmune disease. We examined the role of DNA sensor pathways in a mouse model of inflammatory arthritis in which the lysosomal endonuclease DNaseII is deficient. In this model, DNA accrual results in production of proinflammatory cytokines and type I IFNs. Since type I IFNs lead to anemia-related embryonic lethality, co-deletion of the type I IFN receptor is required (DNaseII/IFN-IR double deficient (DKO) mouse).

Methods: To investigate the contribution of DNA sensor pathways to inflammatory polyarthritis, genes involved in DNA sensor signaling were deleted on the DKO background, yielding three triple knock out (TKO) strains: STING TKO, AIM2 TKO and Unc93 TKO mice. Inflammation was assessed by clinical scoring (scale of 1-12) and by scoring of histologic inflammation in ankle joints (scale of 1-4). Anti-nuclear antibody (ANA) staining was evaluated as another marker of disease. To determine whether STING contributes to inflammation in immune-complex mediated arthritis, serum transfer arthritis (STA) was induced in STING-/- and littermate control mice.

Results: DKO mice develop significant distal polyarthritis. Clinical joint inflammation was completely absent in STING TKO mice, confirming a prior report (Ahn et al., PNAS 109:19386, 2013). However, STING deficiency did not diminish inflammation in the STA model, demonstrating that STING contributes to arthritis in the setting of DNA accrual. Clinical inflammation was significantly reduced in both AIM2 TKO and Unc93 TKO mice compared to DKO mice, demonstrating a role for the inflammasome and TLRs. Average clinical scores: DKO = 5, Het control mice = 0, STING TKO = 0, Unc93 TKO = 4, AIM2 TKO= 3.5 (p<0.05 for all strains compared to DKO). Histologic inflammation scores showed a similar pattern (DKO = 3.5, Het = 0, STING TKO = 0.5, AIM2 TKO = 2, Unc93 TKO = 3 (p<0.05 for all strains compared to DKO). The bright ANA staining pattern generated from sera of DKO mice was completely abrogated in the Unc93 TKO, but was unchanged in the STING TKO and AIM2 TKO strains.

Conclusion: These data indicate that stimulation of several innate immune sensor pathways by endogenous DNA can contribute to inflammatory polyarthritis. Although deletion of STING had the greatest impact in abrogating arthritis, the AIM2 and Unc93 pathways also contributed to joint inflammation. The TLR/Unc93 pathway, but not the STING or AIM2 pathways, mediated ANA production. These data are directly relevant to clarifying the mechanisms by which polyarthritis occurs in SLE and suggest new targets for treatment. In addition, these data demonstrate that distinct DNA sensing pathways play unique roles in disease mechanisms.


Disclosure:

R. Baum,
None;

S. Sharma,
None;

S. Pawaria,
None;

S. Carpenter,
None;

K. A. Fitzgerald,
None;

A. Marshak-Rothstein,
None;

E. M. Gravallese,

AbbVie,

2,

Eli Lilly and Company,

2.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dna-sensors-regulate-inflammation-in-a-model-of-autoimmune-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology